BG
AGTC

BlackRock Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

BlackRock Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$362K Hold
38,703
– – ﹤0.01% 2464
2016
Q3 		$379K Buy
38,703
+35,449
+1,089% +$478K ﹤0.01% 2403
2016
Q2 		$46K Hold
3,254
– – ﹤0.01% 2932
2016
Q1 		$45K Buy
+3,254
New +$47.7K ﹤0.01% 2942

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's AGTC Position: Q4 2016 in Review

BlackRock Group held its Applied Genetic Technologies Corporation (AGTC) position steady in Q4 2016 at 38,703 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

BlackRock Group first reported a position in AGTC in Q1 2016 and has held it in 4 quarters since. The position peaked at $379K in Q3 2016. 90 funds tracked by Wall St. Rank hold AGTC as of Q4 2016.

  • BlackRock Group held 38,703 shares of Applied Genetic Technologies Corporation worth $362K as of Q4 2016.
  • BlackRock Group left its Applied Genetic Technologies Corporation share count unchanged in Q4 2016.
  • Applied Genetic Technologies Corporation made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2464 holding.
  • BlackRock Group first reported a position in Applied Genetic Technologies Corporation in Q1 2016 and has held it in 4 quarters since.
  • BlackRock Group's Applied Genetic Technologies Corporation position peaked at $379K in Q3 2016.
  • 90 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.